The Effect of Relaxation Response Training on Declarative Memory and Learning in High School Students - Full Text View

Sponsors and Collaborators:	Beth Israel Deaconess Medical Center Mind/Body Medical Institute
Information provided by:	Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:	NCT00179504

Purpose

Stress contributes to health and behavioral issues in students, but will not be integrated into schools without evidence of benefit. This study was conducted to determine if a 6-week relaxation response (RR) curriculum improves cognitive performance in ninth grade students.

Condition	Intervention	Phase
Healthy	Behavioral: Relaxation Response	Phase II

MedlinePlus related topics: Memory

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind (Outcomes Assessor), Placebo Control, Factorial Assignment, Efficacy Study
Official Title:	The Effect of Relaxation Response Training on Declarative Memory and Learning in High School Students

Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:

Determine if a 6-week relaxation response (RR) curriculum improves cognitive performance. [ Time Frame: 6 weeks ]

Secondary Outcome Measures:

Evaluate whether the program would influence levels of salivary cortisol and whether there would be a correlation between cortisol levels and performance on the cognitive tasks. [ Time Frame: 6 weeks ]

Enrollment:	90
Study Start Date:	July 2000
Study Completion Date:	September 2007

Intervention Details:

Relaxation training

Detailed Description:

Stress contributes to health and behavioral issues in students, but will not be integrated into schools without evidence of benefit. This study was conducted to determine if a 6-week relaxation response (RR) curriculum improves cognitive performance in ninth grade students.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

a member of 9th grade at a residential preparatory school.

Exclusion Criteria:

none

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00179504

Sponsors and Collaborators

Beth Israel Deaconess Medical Center

Mind/Body Medical Institute

Investigators

Principal Investigator:

Jeffery A Dusek, PhD

Beth Israel Deaconess Medical Center, Mind/Body Medical Institute

More Information

Study ID Numbers:	2001-P-000110
Study First Received:	September 13, 2005
Last Updated:	November 2, 2007
ClinicalTrials.gov Identifier:	NCT00179504
Health Authority:	United States: Food and Drug Administration; United States: Institutional Review Board

Study placed in the following topic categories:

Healthy

ClinicalTrials.gov processed this record on January 14, 2009